Details for New Drug Application (NDA): 020989

✉ Email this page to a colleague

NDA 020989 describes EVOXAC, which is a drug marketed by Cosette and is included in one NDA. It is available from two suppliers. Additional details are available on the EVOXAC profile page.

The generic ingredient in EVOXAC is cevimeline hydrochloride. There are four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the cevimeline hydrochloride profile page.

Summary for 020989

Tradename:	EVOXAC
Applicant:	Cosette
Ingredient:	cevimeline hydrochloride
Patents:	0

Pharmacology for NDA: 020989

Mechanism of Action	Cholinergic Muscarinic Agonists

Suppliers and Packaging for NDA: 020989

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
EVOXAC	cevimeline hydrochloride	CAPSULE;ORAL	020989	NDA	Cosette Pharmaceuticals, Inc.	0713-0883	0713-0883-01	100 CAPSULE in 1 BOTTLE, PLASTIC (0713-0883-01)
EVOXAC	cevimeline hydrochloride	CAPSULE;ORAL	020989	NDA	Cosette Pharmaceuticals, Inc.	0713-0937	0713-0937-01	100 CAPSULE in 1 BOTTLE, PLASTIC (0713-0937-01)

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	30MG
Approval Date:	Jan 11, 2000	TE:	AB	RLD:	Yes

Expired US Patents for NDA 020989

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Cosette	EVOXAC	cevimeline hydrochloride	CAPSULE;ORAL	020989-002	Jan 11, 2000	⤷ Get Started Free	⤷ Get Started Free
Cosette	EVOXAC	cevimeline hydrochloride	CAPSULE;ORAL	020989-002	Jan 11, 2000	⤷ Get Started Free	⤷ Get Started Free
Cosette	EVOXAC	cevimeline hydrochloride	CAPSULE;ORAL	020989-002	Jan 11, 2000	⤷ Get Started Free	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.